Judi van Diessen

890 total citations
14 papers, 460 citations indexed

About

Judi van Diessen is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Judi van Diessen has authored 14 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Surgery. Recurrent topics in Judi van Diessen's work include Lung Cancer Diagnosis and Treatment (7 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Judi van Diessen is often cited by papers focused on Lung Cancer Diagnosis and Treatment (7 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Judi van Diessen collaborates with scholars based in Netherlands, Belgium and Denmark. Judi van Diessen's co-authors include J. Belderbos, Erik van Werkhoven, Jan‐Jakob Sonke, Ludi E. Smeele, Lisette van der Molen, Andrei Barasch, Liset Lansaat, Judith E. Raber‐Durlacher, Judith A. E. M. Zecha and W. Martin C. Klop and has published in prestigious journals such as Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Judi van Diessen

12 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judi van Diessen Netherlands 7 287 201 123 82 73 14 460
Woo Kyung Chung South Korea 9 174 0.6× 124 0.6× 61 0.5× 30 0.4× 60 0.8× 18 422
Angie Giotis Canada 9 85 0.3× 200 1.0× 131 1.1× 38 0.5× 25 0.3× 18 418
Nakashi Sasano Japan 12 292 1.0× 134 0.7× 65 0.5× 43 0.5× 176 2.4× 14 483
Sumin Shin South Korea 16 550 1.9× 98 0.5× 155 1.3× 27 0.3× 4 0.1× 66 786
David Skarsgard Canada 13 205 0.7× 68 0.3× 112 0.9× 114 1.4× 93 1.3× 25 450
Frank Atkins United States 13 69 0.2× 318 1.6× 95 0.8× 10 0.1× 63 0.9× 25 692
Lesley Russell United States 4 364 1.3× 355 1.8× 134 1.1× 296 3.6× 124 1.7× 6 647
Moon-Sing Lee Taiwan 11 50 0.2× 26 0.1× 71 0.6× 82 1.0× 20 0.3× 17 406
Michael A. Samuels United States 12 141 0.5× 41 0.2× 159 1.3× 107 1.3× 27 0.4× 35 419
Gyu Young Chai South Korea 10 103 0.4× 54 0.3× 53 0.4× 27 0.3× 102 1.4× 14 335

Countries citing papers authored by Judi van Diessen

Since Specialization
Citations

This map shows the geographic impact of Judi van Diessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judi van Diessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judi van Diessen more than expected).

Fields of papers citing papers by Judi van Diessen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judi van Diessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judi van Diessen. The network helps show where Judi van Diessen may publish in the future.

Co-authorship network of co-authors of Judi van Diessen

This figure shows the co-authorship network connecting the top 25 collaborators of Judi van Diessen. A scholar is included among the top collaborators of Judi van Diessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judi van Diessen. Judi van Diessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Belderbos, J., Bart Reymen, Maarten Lambrecht, et al.. (2025). Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost Trial. International Journal of Radiation Oncology*Biology*Physics. 122(5). 1227–1237.
2.
Ruysscher, Dirk De, Bart Reymen, Maarten Lambrecht, et al.. (2021). Sites of First Progression in the Randomized PET-Boost Trial for Patients With Locally Advanced NSCLC. International Journal of Radiation Oncology*Biology*Physics. 111(3). S91–S91.
3.
Ruysscher, Dirk De, Bart Reymen, Maarten Lambrecht, et al.. (2021). OA02.05 Local, Regional and Pulmonary Failures in the Randomised PET-Boost Trial for NSCLC Patients. Journal of Thoracic Oncology. 16(3). S105–S105. 3 indexed citations
4.
Heuvel, Michel M. van den, Judi van Diessen, Heike Peulen, et al.. (2020). Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer. Clinical Cancer Research. 27(5). 1256–1266. 39 indexed citations
5.
Ruysscher, Dirk De, Bart Reymen, Maarten Lambrecht, et al.. (2020). OC-0609: The PET-boost trial: isotoxic homogeneous or FDG-directed dose escalation in stage II-III NSCLC. Radiotherapy and Oncology. 152. S345–S346. 4 indexed citations
6.
Diessen, Judi van, Dirk De Ruysscher, Jan‐Jakob Sonke, et al.. (2018). The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial). Radiotherapy and Oncology. 131. 166–173. 53 indexed citations
7.
Vogel, Wouter V., Judi van Diessen, Wouter van Elmpt, et al.. (2018). A secondary analysis of FDG spatio-temporal consistency in the randomized phase II PET-boost trial in stage II–III NSCLC. Radiotherapy and Oncology. 127(2). 259–266. 4 indexed citations
8.
Diessen, Judi van, et al.. (2017). Heart dose associated with overall survival in locally advanced NSCLC patients treated with hypofractionated chemoradiotherapy. Radiotherapy and Oncology. 125(1). 62–65. 38 indexed citations
9.
Zecha, Judith A. E. M., Judith E. Raber‐Durlacher, Raj Nair, et al.. (2016). Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols. Supportive Care in Cancer. 24(6). 2793–2805. 170 indexed citations
10.
Walraven, Iris, Michel M. van den Heuvel, Judi van Diessen, et al.. (2016). Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab. Radiotherapy and Oncology. 118(3). 442–446. 54 indexed citations
11.
12.
Diessen, Judi van, Jan‐Jakob Sonke, E. Damen, et al.. (2015). OC-0204: The first toxicity results of the PET-boost trial (NCT01024829). Radiotherapy and Oncology. 115. S102–S103. 2 indexed citations
13.
Diessen, Judi van, J. Belderbos, Harm van Tinteren, et al.. (2013). VERY HIGH RADIATION DOSE ESCALATION IN NSCLC DOES NOT LEAD TO UNEXPECTED TOXICITY: A PLANNED TOXICITY ANALYSIS OF THE PET-BOOST STUDY (NCT01024829). 8. 1 indexed citations
14.
Kortmann, W., et al.. (2008). 5-Oxoproline as a cause of high anion gap metabolic acidosis: an uncommon cause with common risk factors.. PubMed. 66(8). 354–7. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026